<?xml version="1.0" encoding="UTF-8"?>
<p>The frequency of CD57
 <sup>+</sup>KLRG1
 <sup>+</sup> cells was also increased within CD27
 <sup>−</sup>CD28
 <sup>−</sup>CD4
 <sup>+</sup> and CD27
 <sup>−</sup>CD28
 <sup>−</sup>CD8
 <sup>+</sup> T cell subsets in CMV
 <sup>+</sup> participants (
 <xref ref-type="fig" rid="fig3">Fig. 3 D</xref>). While the majority (&gt;70%) of CD27
 <sup>−</sup>CD28
 <sup>−</sup>CD4
 <sup>+</sup> T cells were CD57
 <sup>−</sup>KLRG1
 <sup>−</sup> in CMV
 <sup>−</sup> participants, over half of this subset expressed CD57 and KLRG1 in CMV
 <sup>+</sup> participants. Similarly, CD57 and KLRG1 expression was increased in CD27
 <sup>−</sup>CD28
 <sup>−</sup> CD8
 <sup>+</sup> T cells in CMV
 <sup>+</sup> individuals. These findings demonstrate that there is an expansion of highly differentiated CD4
 <sup>+</sup> and CD8
 <sup>+</sup> T cells expressing markers of senescence even in young CMV
 <sup>+</sup> adults.
</p>
